AUS
NZ
UK
CA
USA
IND
On July 27, 2026, Translational Development Acquisition Corp. (NASDAQ:TDAC) announced a subscription agreement with Naetas Holding Limited, an accredited institutional investor, to acquire 5 million Class A ordinary shares at $10.00 each, totaling a $50 million PIPE (private investment in public equity) investment. This capital injection is contingent upon the completion of the previously disclosed business combination with ProLogium Holding Inc. and includes the issuance of 5 million warrants to Naetas at no additional cost.
Key Highlights
- NASDAQ symbols: TDAC and TDACW (warrants)
- Naetas Holding Limited committed to purchase 5 million Class A shares at $10 per share, totaling $50 million
- Subscription agreement signed on July 27, 2026; closing expected one business day before the merger completion
- Subscriber receives 5 million warrants exercisable at $11.50 per share, matching TDAC's public warrants
- ProLogium to file resale registration within 45 days post-closing and aim for effectiveness within 90 days
Details of Investment Structure and Share Subscription
Per the agreement dated July 27, 2026, Naetas Holding Limited agreed to purchase 5,000,000 Class A ordinary shares of TDAC at $10.00 each, amounting to $50 million. This PIPE transaction is designed to provide committed capital supporting the business combination with ProLogium, a common financing approach in SPAC mergers.
The subscribed shares have a par value of $0.0001 each. Upon closing the first merger under the Business Combination Agreement, these 5 million shares will convert into ProLogium Class A ordinary shares, maintaining the subscriber's ownership stake through the corporate restructuring.
Warrant Issuance and Terms
Alongside the share purchase, TDAC will issue 5 million warrants to Naetas Holding Limited at no extra cost. These warrants, termed Subscribed Warrants, mirror the terms of TDAC's public warrants, each exercisable for one Class A share at $11.50. This grants the subscriber potential upside if the share price exceeds this exercise price.
The warrants feature a redemption trigger at $18.00 per share with a redemption price of $0.01 per warrant. The agreement specifies no downward price resets, ratchets, or additional protective adjustments beyond standard anti-dilution provisions. Upon the first merger's completion, unexercised warrants will convert into ProLogium warrants as stipulated in the Business Combination Agreement.
Subscription Closing Timing and Conditions
The subscription closing is anticipated one business day before the initial merger closing, ensuring funds are secured prior to merger completion. Naetas Holding will deposit the $50 million into escrow ahead of the Business Combination closing.
Closing obligations are subject to standard conditions, including accurate representations, covenant compliance, absence of prohibitive laws, and merger scheduling. If the Business Combination does not close within the agreed timeframe, the purchase price will be refunded and any issued securities canceled.
Registration Rights and Liquidity Provisions
ProLogium commits to commercially reasonable efforts to file a resale registration statement covering the resale of ProLogium shares and warrants issued to Naetas, including shares issuable upon warrant exercise. This filing must occur within 45 calendar days post-closing and not before the Form F-4 registration statement for the Business Combination is effective.
ProLogium aims to have the resale registration effective within 90 calendar days of filing, extendable to 120 days if under SEC review, or within 10 business days after notification of no further review. If the Form F-4 includes an effective resale prospectus for all registrable securities, this separate filing obligation is deemed satisfied.
Most Favored Nation Clause and Exclusivity
The Subscription Agreement contains a most favored nation provision ensuring Naetas Holding receives terms no less favorable than any subsequent PIPE investors before closing. TDAC and ProLogium cannot amend or enter agreements providing better terms to others without extending those terms to Naetas on a comparable basis.
This clause safeguards institutional investors by preventing preferential treatment to competing investors and ensures uniformity in capital raise terms across the PIPE investor group.
Prospective Business Collaboration Discussions
ProLogium and Naetas Holding Limited have agreed to explore potential business collaborations in good faith, potentially involving product enhancements, new features, and proof-of-concept initiatives. The Subscription Agreement does not establish binding terms for these discussions, which remain exploratory.
This framework allows flexibility for future strategic partnerships without obligating either party until definitive agreements are reached.
Background on Business Combination
The subscription agreement supports the business combination outlined in the Agreement and Plan of Merger dated May 27, 2026, involving TDAC, ProLogium Holding Inc., and its wholly owned subsidiaries PLG Merger Sub 1 and PLG Merger Sub 2. The Business Combination Agreement may be amended or modified as needed.
This financing mechanism provides capital for the combined entity post-merger. Both TDAC and ProLogium are Cayman Islands exempted companies with limited liability. The use of two merger subsidiaries indicates a multi-step merger structure, though specific merger mechanics are not detailed.
Termination Rights and Conditions
The Subscription Agreement terminates upon the earliest of: (i) valid termination of the Business Combination Agreement, (ii) mutual written consent, or (iii) 30 days after the Business Combination's Termination Date if closing has not occurred, provided termination is not due to Naetas Holding's breach.
This termination framework protects both parties, ensuring the subscription is contingent on merger completion and binding unless external factors prevent closing.
Regulatory and Approval Requirements
Issuance of the Subscribed Warrants requires all necessary approvals, consents, and compliance with applicable laws under the Business Combination and warrant agreements. Regulatory or shareholder approvals may be pending, though specifics are not disclosed.
The Form F-4 registration statement filing indicates SEC review is required for the business combination. TDAC is classified as an emerging growth company, which may afford certain regulatory accommodations but does not exempt it from SEC scrutiny.
TDAC Securities and Nasdaq Listing
TDAC's securities traded on Nasdaq include units (TDACU), each comprising one Class A ordinary share and one-half of one redeemable warrant; Class A ordinary shares (TDAC) with a $0.0001 par value; and redeemable warrants (TDACW), each exercisable for one Class A share at $11.50.
This multi-class structure is typical for SPACs, allowing investors to separate units into shares and warrants. The $11.50 warrant exercise price sets the cost to acquire additional shares, while the $18.00 redemption trigger enables TDAC to redeem warrants, limiting investor exposure to price fluctuations.
